C12N 2740/15051
Methods of production or purification of viral material
C12N2740/15051 (Methods of production or purification of viral material) appears on 122 US grants and 268 published applications in this corpus.
Search patents in C12N- Granted patents
- 122
- Published applications
- 268
- Assignees
- 155
- Inventors
- 545
- Latest grant
- 25 Aug 2026
Filings by year
| Year | Granted patents | Published applications |
|---|---|---|
| 1994 | 2 | 0 |
| 1995 | 0 | 0 |
| 1996 | 2 | 0 |
| 1997 | 0 | 0 |
| 1998 | 0 | 0 |
| 1999 | 0 | 0 |
| 2000 | 1 | 0 |
| 2001 | 2 | 1 |
| 2002 | 1 | 2 |
| 2003 | 1 | 8 |
| 2004 | 3 | 3 |
| 2005 | 2 | 6 |
| 2006 | 3 | 3 |
| 2007 | 6 | 5 |
| 2008 | 1 | 5 |
| 2009 | 2 | 4 |
| 2010 | 5 | 4 |
| 2011 | 0 | 3 |
| 2012 | 3 | 3 |
| 2013 | 1 | 3 |
| 2014 | 2 | 4 |
| 2015 | 3 | 5 |
| 2016 | 1 | 6 |
| 2017 | 1 | 11 |
| 2018 | 5 | 11 |
| 2019 | 6 | 14 |
| 2020 | 8 | 13 |
| 2021 | 8 | 17 |
| 2022 | 6 | 19 |
| 2023 | 13 | 21 |
| 2024 | 12 | 41 |
| 2025 | 15 | 29 |
| 2026 | 7 | 27 |
By publication year. Applications have been published since 2001. 2026 runs to 8 Oct.
Subgroups
Granted patents
Recent patents
- Composition of shelf-stable plasmid dna/polyethyleneimine (pei) particles with defined sizes for viral vector production and method for preparation of the same25 Aug 2026US 12,716,073 B2The Johns Hopkins University
- Compositions for transfecting a nucleic acid molecule into a cell comprising benzo-fused heterocyclic compounds grafted to a cationic polymer, and their applications25 Aug 2026US 12,716,075 B2Sartorius Polyplus
- Protein-based purification matrices and methods of using the same28 Jul 2026US 12,692,483 B2Donaldson Company, Inc.
- Spike-in reference standard for use in detecting sample target from DNA or RNA organism26 May 2026US 12,637,726 B2Gene Copoeia, Inc.
- Viral and non-viral nanoplasmid vectors with improved production14 Apr 2026US 12,600,984 B2Aldevron, LLC
- Hybrid transient transfection using transposase for high yield product production8 Oct 2026US 2026/0308275 A1Lonza Biologics PLC
- Production of cells and viral vectors8 Oct 2026US 2026/0308612 A1Biocell Innovations Pte., Ltd.
- Purification of viruses and viral like particles8 Oct 2026US 2026/0308616 A1Interius Biotherapeutics, Inc.
- Kinetically controlled methods to prepare concentrated shelf-stable nucleic acid transfection vehicles8 Oct 2026US 2026/0308631 A1The Johns Hopkins University
- Digital droplet based assay for detecting replication competent lentiviral vector1 Oct 2026US 2026/0297693 A1Sana Biotechnology, Inc.
Most cited
By later US patents
- Lentivirus vector system92US 6,790,657 B1The United States of America as represented by the Department of Health and Human Services · 2004
- Compositions and methods for identifying antigens which elicit an immune response89US 6,500,641 B1Wake Forest University School of Medicine · 2002
- Lentivirus-based gene transfer vectors50US 6,277,633 B1The University of North Carolina at Chapel Hill · 2001
- CCR7 ligand delivery and co-delivery in immunotherapy27US 8,592,364 B2Ecole Polytechnique Federale De Lausanne (Epfl) · 2013
- HIV pre-immunization and immunotherapy25US 10,036,038 B2American Gene Technologies International Inc. · 2018